Document is current
Any future updates will be listed below
-
Authors
Porniece Kumar, Marta https://orcid.org/0000-0003-2330-5846
Cremer, Anna Lena
Klemm, Paul https://orcid.org/0000-0002-5985-1737
Steuernagel, Lukas https://orcid.org/0000-0003-0043-1436
Sundaram, Sivaraj
Jais, Alexander https://orcid.org/0000-0002-9897-4983
Hausen, A. Christine https://orcid.org/0000-0002-5700-7313
Tao, Jenkang
Secher, Anna https://orcid.org/0000-0002-6276-5389
Pedersen, Thomas Åskov
Schwaninger, Markus https://orcid.org/0000-0002-4510-9718
Wunderlich, F. Thomas https://orcid.org/0000-0002-9209-3501
Lowell, Bradford B.
Backes, Heiko
Brüning, Jens C. https://orcid.org/0000-0002-6619-0092
- License Information
-
More Information
Article History
Received: 6 April 2021
Accepted: 26 October 2021
First Online: 20 December 2021
Competing interests
: A.S. and T.Å.P. are current employees and stakeholders at Novo Nordisk A/S. The labelled insulin was provided by Novo Nordisk as well. The other authors declare no competing interests.
